{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:38:42Z","timestamp":1792809522956,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"PolyU - Rohto Centre of Research Excellence for Eye Care","award":["P0046333"],"award-info":[{"award-number":["P0046333"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40123-026-01494-y","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:06:15Z","timestamp":1789041975000},"page":"3681-3696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Three-year Comparative Efficacy and Safety of Repeated Low-level Red-light Therapy and Orthokeratology for Myopia Control in Children"],"prefix":"10.1007","volume":"15","author":[{"given":"Aiqin","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingguang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"issue":"3","key":"1494_CR1","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.1167\/iovs.18-25957","volume":"60","author":"DI Flitcroft","year":"2019","unstructured":"Flitcroft DI, He M, Jonas JB, et al. IMI\u2014defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019;60(3):M20\u201330. https:\/\/doi.org\/10.1167\/iovs.18-25957.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1494_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2000","unstructured":"Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2000;123(5):1036\u201342. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.006.","journal-title":"Ophthalmology"},{"issue":"3","key":"1494_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/bjo-2024-325427","volume":"109","author":"J Liang","year":"1990","unstructured":"Liang J, Pu Y, Chen J, et al. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. Br J Ophthalmol. 1990;109(3):362\u201371. https:\/\/doi.org\/10.1136\/bjo-2024-325427.","journal-title":"Br J Ophthalmol"},{"key":"1494_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010332","author":"Q Xiao","year":"2025","unstructured":"Xiao Q, Zhang X, Chen ZL, et al. An evidence-based narrative review of scleral hypoxia theory in myopia: from mechanisms to treatments. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26010332.","journal-title":"Int J Mol Sci"},{"key":"1494_CR5","doi-asserted-by":"publisher","unstructured":"Lawrenson J, Dhakal R, Verkicharla P, et al. Interventions for myopia control in children: a living systematic review and network meta-analysis Cochrane Libr. 2021; https:\/\/doi.org\/10.1002\/14651858.cd014758","DOI":"10.1002\/14651858.cd014758"},{"key":"1494_CR6","doi-asserted-by":"publisher","unstructured":"Yam JC, Jiang Y, Tang SM, et al. Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology. 2018;126(1):113\u2013124. https:\/\/doi.org\/10.1016\/j.ophtha.2018.05.029","DOI":"10.1016\/j.ophtha.2018.05.029"},{"issue":"3","key":"1494_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2019","unstructured":"Lam CSY, Tang WC, Tse DY, et al. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2019;104(3):363\u20138. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313739.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1494_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","volume":"140","author":"J Bao","year":"2022","unstructured":"Bao J, Huang Y, Li X, et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmol. 2022;140(5):472\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.0401.","journal-title":"JAMA Ophthalmol"},{"key":"1494_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2024-001790","author":"D Laughton","year":"2024","unstructured":"Laughton D, Hill JS, McParland M, et al. Control of myopia using diffusion optics spectacle lenses: 4-year results of a multicentre randomised controlled, efficacy and safety study (CYPRESS). BMJ Open Ophthalmol. 2024. https:\/\/doi.org\/10.1136\/bmjophth-2024-001790.","journal-title":"BMJ Open Ophthalmol"},{"issue":"11","key":"1494_CR10","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","volume":"53","author":"P Cho","year":"2012","unstructured":"Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophth Vis Sci. 2012;53(11):7077\u201385. https:\/\/doi.org\/10.1167\/iovs.12-10565.","journal-title":"Invest Ophth Vis Sci"},{"key":"1494_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030662","author":"A Queir\u00f3s","year":"2025","unstructured":"Queir\u00f3s A, Pinheiro I, Fernandes P. Peripheral defocus in orthokeratology myopia correction: systematic review and meta-analysis. J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14030662.","journal-title":"J Clin Med"},{"issue":"5","key":"1494_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ophtha.2021.11.023","volume":"129","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Zhu Z, Tan X, et al. Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial. Ophthalmology. 2021;129(5):509\u201319. https:\/\/doi.org\/10.1016\/j.ophtha.2021.11.023.","journal-title":"Ophthalmology"},{"issue":"10","key":"1494_CR13","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.7150\/ijms.85746","volume":"20","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Cao X, Zhang Y, et al. Repeated low-level red-light therapy for controlling onset and progression of myopia-a review. Int J Med Sci. 2023;20(10):1363\u201376. https:\/\/doi.org\/10.7150\/ijms.85746.","journal-title":"Int J Med Sci"},{"issue":"6","key":"1494_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjo.2024.100124","volume":"13","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xiong R, Yang S, et al. Safety of repeated low-level red-light therapy for myopia: a systematic review. Asia Pac J Ophthalmol. 2024;13(6):100124. https:\/\/doi.org\/10.1016\/j.apjo.2024.100124.","journal-title":"Asia Pac J Ophthalmol"},{"issue":"2","key":"1494_CR15","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s40123-023-00671-7","volume":"12","author":"W Wang","year":"2023","unstructured":"Wang W, Jiang Y, Zhu Z, et al. Axial shortening in myopic children after repeated low-level red-light therapy: post hoc analysis of a randomized trial. Ophthalmol Ther. 2023;12(2):1223\u201337. https:\/\/doi.org\/10.1007\/s40123-023-00671-7.","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"1494_CR16","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00417-022-05901-5","volume":"261","author":"J Chen","year":"2022","unstructured":"Chen J, Liu S, Zhu Z, et al. Axial length changes in progressive and non-progressive myopic children in China. Graefes Arch Clin Exp Ophthalmol. 2022;261(5):1493\u2013501. https:\/\/doi.org\/10.1007\/s00417-022-05901-5.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"1494_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/OPX.0000000000002197","volume":"101","author":"JR Sun","year":"2024","unstructured":"Sun JR, Du ZQ, Wu GY. Efficacy comparison of repeated low-level red-light therapy and orthokeratology lenses for myopia control. Optom Vis Sci. 2024;101(11):660\u20135. https:\/\/doi.org\/10.1097\/OPX.0000000000002197.","journal-title":"Optom Vis Sci"},{"issue":"2","key":"1494_CR18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s40123-022-00644-2","volume":"12","author":"W Wang","year":"2023","unstructured":"Wang W, Jiang Y, Zhu Z, et al. Clinically significant axial shortening in myopic children after repeated low-level red light therapy: a retrospective multicenter analysis. Ophthalmol Ther. 2023;12(2):999\u20131011. https:\/\/doi.org\/10.1007\/s40123-022-00644-2.","journal-title":"Ophthalmol Ther"},{"issue":"11","key":"1494_CR19","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.ophtha.2024.05.023","volume":"131","author":"Y Xu","year":"2024","unstructured":"Xu Y, Cui L, Kong M, et al. Repeated low-level red light therapy for myopia control in high myopia children and adolescents: a randomized clinical trial. Ophthalmology. 2024;131(11):1314\u201323. https:\/\/doi.org\/10.1016\/j.ophtha.2024.05.023.","journal-title":"Ophthalmology"},{"issue":"3","key":"1494_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40123-023-00875-x","volume":"13","author":"Z Liu","year":"2024","unstructured":"Liu Z, Sun Z, Du B, et al. The effects of repeated low-level red-light therapy on the structure and vasculature of the choroid and retina in children with premyopia. Ophthalmol Ther. 2024;13(3):739\u201359. https:\/\/doi.org\/10.1007\/s40123-023-00875-x.","journal-title":"Ophthalmol Ther"},{"issue":"9","key":"1494_CR21","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s00417-023-06066-5","volume":"261","author":"P Zhang","year":"2023","unstructured":"Zhang P, Zhang X, Zhu H. Photobiomodulation at 660 nm promotes collagen synthesis via downregulation of HIF-1\u03b1 expression without photodamage in human scleral fibroblasts in vitro in a hypoxic environment. Graefes Arch Clin Exp Ophthalmol. 2023;261(9):2535\u201345. https:\/\/doi.org\/10.1007\/s00417-023-06066-5.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"1494_CR22","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1038\/s41598-025-31458-4","volume":"16","author":"L Huang","year":"2025","unstructured":"Huang L, Gao M, Ma A, et al. Effects of different powers of repeated low-level red light on form-deprivation myopia inhibition in guinea pigs. Sci Rep-UK. 2025;16(1):1818. https:\/\/doi.org\/10.1038\/s41598-025-31458-4.","journal-title":"Sci Rep-UK"},{"issue":"12","key":"1494_CR23","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.12.39","volume":"66","author":"MA Bullimore","year":"2025","unstructured":"Bullimore MA, Saunders KJ, Baraas RC, et al. IMI-interventions for controlling myopia onset and progression 2025. Invest Ophthalmol Vis Sci. 2025;66(12):39. https:\/\/doi.org\/10.1167\/iovs.66.12.39.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1494_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2025-328687","author":"Y Chen","year":"2026","unstructured":"Chen Y, Wang W, Xiong R, et al. Three-year efficacy and safety of repeated low-level red-light therapy for myopia control: a multicentre real-world study. Br J Ophthalmol. 2026. https:\/\/doi.org\/10.1136\/bjo-2025-328687.","journal-title":"Br J Ophthalmol"},{"key":"1494_CR25","doi-asserted-by":"publisher","unstructured":"Chen Y, Wu Y, Wang L, et al. Efficacy of red light for myopia control from age 2 to 24 with diverse treatment periods: a real-world study. Photodiagn Photodyn. 2026;59:105481. https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105481","DOI":"10.1016\/j.pdpdt.2026.105481"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01494-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01494-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01494-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:02:34Z","timestamp":1792807354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01494-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01494-y","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"19 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Aiqin Nie has nothing to disclose. Jing Xie has nothing to disclose. Yingshi Zou has nothing to disclose. Ming-Ming Yang has nothing to disclose. Yanxian Chen has nothing to disclose. Mingguang He reports being a director and shareholder of Eyerising Ltd and Eyerising International Pty Ltd.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Shenzhen People\u2019s Hospital (LL-KY-2026156-01). The requirement for informed consent was waived by the Ethics Committee because of the retrospective nature of the study.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}